Stay updated with breaking news from Disease Modifying Agents. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
250 Pages Disease – Modifying Agents Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderIn the struggle to slow the progression of disease in many inflammatory conditions such as rheumatoid arthritis, psoriasis, and psoriatic arthritis, the disease-modifying agent class, including trea...
Diadem Presents Clinical Data and Commercialization Plans for Its AlzoSure® Prognostic Biomarker Test at 2020 Alzheimer's Disease International Conference -- Blood-Based AlzoSure Assay Has Potential to Transform Management of Alzheimer's Disease by Identifying Patients Early in the Disease Process -- News provided by Share this article Share this article MILAN, Dec. 11, 2020 /PRNewswire/ -- Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today reported that it hosted a Symposium on its prognostic biomarker test at the 34 th A...